Goldman Sachs Alternatives

Goldman Sachs Alternatives accounts for 22 tracked companies with verified cap-table data, 22 of which disclose round sizes totalling $8.6B. The median disclosed raise is $250M, and the largest is QScale at $1.3B, ahead of OneAdvanced ($1.2B) and Producers Midstream ($1.1B).

The names that recur most often on these portfolio cap tables are Goldman Sachs Alternatives (22 companies), General Catalyst (2 companies), B Capital (2 companies), Janus Henderson Investors (2 companies), Cormorant Asset Management (2 companies), OrbiMed (2 companies). By latest disclosed round, the market skews Growth (5), Series B (5), Series A (4), Series C (3).

• Companies tracked: 22
• Disclosed funding total: $8.6B across 22 companies
• Median disclosed raise: $250M
• Largest raise: QScale — $1.3B
• Stage mix: Growth 5 · Series B 5 · Series A 4 · Series C 3
• Most recent dated round: 2026-06-01

Best funded Goldman Sachs Alternatives companies

1. QScale — $1.3B (latest: Growth)
2. OneAdvanced — $1.2B (latest: Growth)
3. Producers Midstream — $1.1B (latest: Growth)
4. Judi Health — $607M (latest: Series F)
5. Hydrostor — $550M (latest: Growth)
6. Neural Concept — $548M (latest: Series B)
7. AIDOC — $500M (latest: Series E)
8. Kashable — $450M (latest: Series B)
9. Bright Night — $440M (latest: Growth)
10. Triveni Bio — $277M (latest: Series C)
11. MoEngage — $250M (latest: Series E)
12. Alterome Therapeutics — $231M (latest: Series A)
13. Federato — $180M (latest: Series D)
14. Third Arc Bio — $165M (latest: Series A)
15. osapiens — $147M (latest: Series B)

Goldman Sachs Alternatives — related firms and companies (56)

• QScale
• OneAdvanced
• Producers Midstream
• Judi Health
• Hydrostor
• Neural Concept
• AIDOC
• Kashable
• Investors like Uncork Capital
• Investors like Expansion Venture Capital
• Fieldguide
• Investors like Thrive Capital
• Investors like Draper Associates
• Investors like Goldman Sachs Alternatives
• Bright Night
• Investors like AME Cloud Ventures
• Investors like Sequoia Capital
• Ajax Therapeutics
• Investors like Soma Capital
• Investors like SOSV
• Goldman Sachs Alternatives co-investors 2026
• Investors like Balderton Capital
• Investors like Western Technology Investment
• Investors like Canaan Partners
• osapiens
• Investors like QED Investors
• Investors like IVP
• evolvedMD
• Investors like Lightspeed Venture Partners
• Investors like F-Prime
• Investors like Spark Capital
• Third Arc Bio
• Investors like Forerunner
• Investors like Service Provider Capital
• Cubby Storage
• Investors like Menlo Ventures
• Investors like Shasta Ventures
• Investors like Headline
• Federato
• Investors like General Catalyst
• Investors like Techstars Ventures
• Newleos Therapeutics
• Investors like Tiger Global Management
• Investors like Trinity Ventures
• Investors like Scale Venture Partners
• Alterome Therapeutics
• Investors like Mayfield Fund
• Investors like Script Capital
• Newtek Merchant Solutions
• Investors like Madrona
• Investors like Zetta Venture Partners
• Investors like Torch Capital
• MoEngage
• Investors like Correlation Ventures
• Investors like Maven Ventures
• Vicebio

Goldman Sachs Alternatives alternatives · All research reports